Trump calls on FDA to cut ‘red tape’ as coronavirus drug trials gather pace

Finally, Merck KGaA has donated  a supply of its  interferon beta-1a product Rebif – approved for multiple sclerosis - to France’s INSERM research organisation following a request for use in a

Staying ahead in the era of precision medicine

to our advisory board Co-Chair Dr Zhen Su, Head of Merck KGaA’s global oncology franchise.

Merck KGaA, Pfizer’s Bavencio stumbles in head and neck cancer

Checkpoint inhibitor unlikely to improve progression-free survival. Merck KGaA and Pfizer have hit a bump in the road in their efforts to extend the reach of Bavencio, their late-comer ... Merck KGaA/Pfizer’s drug then picked up an approval in

AstraZeneca’s Imfinzi fails first-line bladder cancer test

At the moment, Tecentriq’s only direct competitor in the frontline setting is Merck &Co’s PD-1 inhibitor Keytruda (pembrolizumab), which is also approved for first-line use in ... inhibitors including Bristol-Myers Squibb’s Opdivo (nivolumab) and

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]